A clinical trial has shown that the immunotherapy drug pembrolizumab increased survival rates for head and neck cancer patients with intermediate risk.
Forschungsgruppe Quanteneffekte bei Krankheiten (qrdrg.xonl.de)
Copyright © 2024 MEDIZIN.NEWZS.de - Quantum Related Diseases Research Group (QRDRG)